A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
Woman dies in Carouge after home attack
French speaking cantons unite against SSR vote
US is now in surplus with Swiss trade
Migros recalls baby formula
Geneva teachers warn over Roblox
Italy angered at decision to release fire bar owner
